Literature DB >> 26602219

Time to Replace Assessment of Liver Histology With MR-Based Imaging Tests to Assess Efficacy of Interventions for Nonalcoholic Fatty Liver Disease.

Christopher D Byrne1, Giovanni Targher2.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26602219     DOI： 10.1053/j.gastro.2015.11.016

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  14 in total

1.  EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease: is universal screening appropriate?

Authors:  Christopher D Byrne; Giovanni Targher
Journal:  Diabetologia       Date:  2016-04-07       Impact factor: 10.122

Review 2.  Lessons learnt from pathologic imaging correlation in the liver: an historical perspective.

Authors:  Yvonne Purcell; Pauline Copin; Valérie Paradis; Valérie Vilgrain; Maxime Ronot
Journal:  Br J Radiol       Date:  2019-01-10       Impact factor: 3.039

3.  Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease.

Authors:  Asmaa S Abdelhamid; Tracey J Brown; Julii S Brainard; Priti Biswas; Gabrielle C Thorpe; Helen J Moore; Katherine Ho Deane; Fai K AlAbdulghafoor; Carolyn D Summerbell; Helen V Worthington; Fujian Song; Lee Hooper
Journal:  Cochrane Database Syst Rev       Date:  2018-11-30

Review 4.  Liver fat: a relevant target for dietary intervention? Summary of a Unilever workshop.

Authors:  Harry P F Peters; Patrick Schrauwen; Petra Verhoef; Christopher D Byrne; David J Mela; Andreas F H Pfeiffer; Ulf Risérus; Frits R Rosendaal; Vera Schrauwen-Hinderling
Journal:  J Nutr Sci       Date:  2017-05-08

5.  Structure of proof of concept studies that precede a nonalcoholic steatohepatitis development program.

Authors:  R N Williams; C Filozof; B J Goldstein; K Cusi
Journal:  Clin Pharmacol Ther       Date:  2016-12-29       Impact factor: 6.875

6.  Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease.

Authors:  Asmaa S Abdelhamid; Nicole Martin; Charlene Bridges; Julii S Brainard; Xia Wang; Tracey J Brown; Sarah Hanson; Oluseyi F Jimoh; Sarah M Ajabnoor; Katherine Ho Deane; Fujian Song; Lee Hooper
Journal:  Cochrane Database Syst Rev       Date:  2018-11-27

Review 7.  Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease.

Authors:  Asmaa S Abdelhamid; Tracey J Brown; Julii S Brainard; Priti Biswas; Gabrielle C Thorpe; Helen J Moore; Katherine Ho Deane; Fai K AlAbdulghafoor; Carolyn D Summerbell; Helen V Worthington; Fujian Song; Lee Hooper
Journal:  Cochrane Database Syst Rev       Date:  2018-07-18

Review 8.  Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease.

Authors:  Asmaa S Abdelhamid; Nicole Martin; Charlene Bridges; Julii S Brainard; Xia Wang; Tracey J Brown; Sarah Hanson; Oluseyi F Jimoh; Sarah M Ajabnoor; Katherine Ho Deane; Fujian Song; Lee Hooper
Journal:  Cochrane Database Syst Rev       Date:  2018-07-18

9.  Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease.

Authors:  Asmaa S Abdelhamid; Tracey J Brown; Julii S Brainard; Priti Biswas; Gabrielle C Thorpe; Helen J Moore; Katherine Ho Deane; Carolyn D Summerbell; Helen V Worthington; Fujian Song; Lee Hooper
Journal:  Cochrane Database Syst Rev       Date:  2020-02-29

10.  Nonalcoholic fatty liver disease and increased risk of 1-year all-cause and cardiac hospital readmissions in elderly patients admitted for acute heart failure.

Authors:  Filippo Valbusa; Stefano Bonapace; Davide Agnoletti; Luca Scala; Cristina Grillo; Pietro Arduini; Emanuela Turcato; Alessandro Mantovani; Giacomo Zoppini; Guido Arcaro; Christopher Byrne; Giovanni Targher
Journal:  PLoS One       Date:  2017-03-13       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.